Cancer diagnostics company creates medical advisory board with GI experts

Eric Oliver - Print  |

Cernostics created a medical advisory board with experts on gastroesophageal reflux disease, Barrett's esophagus and esophageal cancer to assist the company going forward.

What you should know:

1. The board includes:

2. Cernostics creates tissue-based diagnostic tests that aim to improve patient outcomes and lower care costs.

"Timing is right to bring together this world-class group of medical advisors to provide strategic insights into our evidence development and market access strategies," said Cernostics CEO Mike Hoerres.

More articles on gastroenterology:
3 things to know about outpatient cervical disc replacement
10 things to know about spine surgery for ASCs in 2019
Outpatient revision minimally invasive lumbar decompression: 4 notes on ASC vs. HOPD

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.